These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 240891)

  • 1. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action.
    Shand FL
    Immunology; 1976 Dec; 31(6):943-51. PubMed ID: 11181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Shand FL
    Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective removal of T cell function from mouse lymphocyte suspensions by treatment with normal guinea pig serum.
    Kierszenbaum F; Budzko DB; Miller HC
    J Immunol; 1980 Apr; 124(4):1599-602. PubMed ID: 6988503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor T cells arising in mice undergoing a graft-vs-host response.
    Pickel K; Hoffmann MK
    J Immunol; 1977 Feb; 118(2):653-6. PubMed ID: 14213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ly and Ia phenotype of suppressor T cells induced by graft-vs.-host reaction.
    Shand FL
    Eur J Immunol; 1977 Oct; 7(10):746-8. PubMed ID: 73466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
    Budhecha S; Hamilton BL
    J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
    Holda JH; Maier T; Claman HN
    J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
    Polisson RP; Shearer GM
    J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
    Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
    Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
    Golding H; Rittenberg MB
    J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.
    Scheinberg MA; Cathcart ES
    Immunology; 1974 Nov; 27(5):953-63. PubMed ID: 4154917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.